posted 26th January 2022
ASCAT 2022 - New Therapies Session
The National Haemoglobinopathy Panel (NHP) are pleased so share this insightful and hopeful video on new therapies, as part of the Annual Scientific Conference on Sickle Cell and Thalassemia, which took place 26th to 28th January 2022.
Chairs: Professor Biree Andemariam and Dr Miguel Abboud
1. Title: Early Evaluation of the Use of Crizanlizumab in Sickle Cell Disease: A National Alliance of Sickle Cell Centers Study Clinician: Dr Julie Kanter MD | University of AL Birmingham
[00:00 - 15:34]
2. Title: Real-Life Experience of Novel Therapies Use: Voxelotor RETRO/PROSPECT Studies Clinician: Professor Biree Andermariam, MD |New England Sickle Cell Institute, Connecticut Bleeing Disorders Centre, University of Connecticut Health
[ 15:34 - 44:17]
3. Title: Emerging Sickle Cell Disease
Clinician: Dr Bart J. Biemond | Amsterdam University Medical Centers
[ 44:18 - 1:15:33 ]
